The long noncoding RNA FEDORA is a cell type- and sex-specific regulator of depression.
Orna IsslerYentl Y van der ZeeAarthi RamakrishnanSun-Hui XiaAlexander K ZinsmaierChunfeng TanWei LiCaleb J BrowneDeena M WalkerMarine SaleryAngelica Torres-BerrioRita FutamuraJulia E DuffyBenoit LabonteMatthew J GirgentiCarol A TammingaJeffrey L DupreeYan DongJames W MurroughLi ShenEric J NestlerPublished in: Science advances (2022)
Women suffer from depression at twice the rate of men, but the underlying molecular mechanisms are poorly understood. Here, we identify marked baseline sex differences in the expression of long noncoding RNAs (lncRNAs), a class of regulatory transcripts, in human postmortem brain tissue that are profoundly lost in depression. One such human lncRNA, RP11-298D21.1 (which we termed FEDORA), is enriched in oligodendrocytes and neurons and up-regulated in the prefrontal cortex (PFC) of depressed females only. We found that virally expressing FEDORA selectively either in neurons or in oligodendrocytes of PFC promoted depression-like behavioral abnormalities in female mice only, changes associated with cell type-specific regulation of synaptic properties, myelin thickness, and gene expression. We also found that blood FEDORA levels have diagnostic implications for depressed women and are associated with clinical response to ketamine. These findings demonstrate the important role played by lncRNAs, and FEDORA in particular, in shaping the sex-specific landscape of the brain and contributing to sex differences in depression.
Keyphrases
- depressive symptoms
- long noncoding rna
- gene expression
- sleep quality
- endothelial cells
- prefrontal cortex
- white matter
- transcription factor
- polycystic ovary syndrome
- poor prognosis
- spinal cord
- dna methylation
- multiple sclerosis
- skeletal muscle
- physical activity
- resting state
- spinal cord injury
- long non coding rna
- optical coherence tomography
- pluripotent stem cells
- pain management
- high fat diet induced
- chronic pain
- cerebral ischemia
- middle aged
- cervical cancer screening